Analogic Corporation  

(Public, NASDAQ:ALOG)   Watch this stock  
Find more results for ALOG
84.40
+1.20 (1.44%)
Nov 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 82.95 - 86.53
52 week 66.00 - 95.85
Open 82.95
Vol / Avg. 0.00/63,939.00
Mkt cap 1.07B
P/E     -
Div/yield 0.10/0.47
EPS -5.96
Shares 12.48M
Beta 0.85
Inst. own 102%
Dec 6, 2017
Q1 2018 Analogic Corp Earnings Call - 5:00PM EST - Add to calendar
Dec 6, 2017
Q1 2018 Analogic Corp Earnings Release - 4:00PM EST - Add to calendar
Dec 1, 2017
Analogic Corp Annual Shareholders Meeting - 10:00AM EST - Add to calendar
Sep 19, 2017
Q4 2017 Analogic Corp Earnings Call - Webcast
Sep 19, 2017
Q4 2017 Analogic Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '17) 2017
Net profit margin -22.07% -15.26%
Operating margin -13.95% -13.73%
EBITD margin - 10.22%
Return on average assets -17.86% -12.68%
Return on average equity -20.96% -14.97%
Employees 1,510 -
CDP Score - -

Address

8 Centennial Dr
PEABODY, MA 01960-7902
United States - Map
+1-978-9773000 (Phone)
+1-978-9776809 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company's Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company's Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company's Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.

Officers and directors

Fred B. Parks Ph.D. President, Chief Executive Officer, Director
Age: 70
Bio & Compensation  - Reuters
Michael J. Bourque Chief Financial Officer, Senior Vice President, Treasurer
Age: 54
Bio & Compensation  - Reuters
John J. Fry Senior Vice President, General Counsel, Secretary
Age: 56
Bio & Compensation  - Reuters
Mervat Faltas Senior Vice President, General Manager - Medical Imaging Business Unit
Age: 65
Bio & Compensation  - Reuters
James Patrick Ryan Senior Vice President and General Manager, Security Detection and Power Technologies
Age: 47
Bio & Compensation  - Reuters
Brooks West Senior Vice President, General Manager, Global Ultrasound
Age: 47
Bio & Compensation  - Reuters
Bernard C. Bailey Ph.D. Independent Director
Age: 64
Bio & Compensation  - Reuters
Jeffrey P. Black Independent Director
Age: 57
Bio & Compensation  - Reuters
James J. Judge Independent Director
Age: 61
Bio & Compensation  - Reuters
Michael T. Modic Independent Director
Age: 67
Bio & Compensation  - Reuters